Phase
Condition
Adenocarcinoma
Lung Cancer
Bronchiolo-alveolar Carcinoma (Bac)
Treatment
N/AClinical Study ID
Ages 20-79 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Preoperative criteria: peripheral non-small cell lung cancer, no larger than 2 cm inmaximal diameter, no lymph node metastasis, FEV1%>50% (FEV1: Forced Expiratory Volume in 1second); Preoperative imaging:pure ground-glass or mixed ground-glass nodules (part-solid, solidareas < 0.5cm); Follow-up duration last 3 months or more, HRCT (HRCT: high-resolution computed tomography)lesion maximum diameter was measured three times and took the average, meet the criteria ofclinical surgical indications; Intraoperative criteria: histologically confirmed NSCLC, adenocarcinoma in situ or withmicroinvasion; No prior ipsilateral thoracotomy; No prior anti-neoplastic therapy; EOCG Performance status 0-2; Sufficient organ functions; Written informed consent.
Exclusion
Exclusion Criteria: Active bacterial or fungous infection; Simultaneous or prior (within the past 5 years) other malignant disease; Interstitial pneumonitis, pulmonary fibrosis, or severe COPD (COPD: chronic obstructivepulmonary disease); Abnormal Psychosis; Uncontrollable diabetes mellitus; History of severe cardiovascular disease; Any condition which, in the opinion of the investigator might interfere with the evaluationof the objective.
Study Design
Study Description
Connect with a study center
Nanfang Hospital
Guangzhou, Guangdong
ChinaSite Not Available
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong 510000
ChinaSite Not Available
First Affiliated Hospital Zhejiang University colleague of Medicine
Hangzhou, Zhejiang
ChinaSite Not Available
Peking University Cancer Hospital
Beijing,
ChinaSite Not Available
China-Japan Friendship hospital
Bejing,
ChinaSite Not Available
Shanghai Chest Hospital
Shanghai,
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.